Alerts
This page shows all our alerts. These are Safety alerts, Medicine shortage alerts and Product recalls. You can sort the list with the filters on the left, use the search bar or both.
For more information see Product safety.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Alert/Advisory (1073)
- Medicines safety (470)
- Medical devices safety (326)
- Medicines (63)
- Shortages (44)
- Prescription medicines (17)
- Safety (14)
- Medical devices (9)
- Blood safety (8)
- Listed medicines (6)
- Unapproved therapeutic goods (5)
- Australian Register of Therapeutic Goods (ARTG) (3)
- Over the counter medicine (3)
- Advertising (2)
- Complementary medicines (2)
- Import and export (2)
- Legislation (2)
- Non-prescription medicines (2)
- Regulatory compliance (2)
- Therapeutic goods regulation (2)
- Biologicals (1)
- Breast implant hub (1)
- Clinical trials (1)
- Labelling and packaging (1)
- Sunscreens (1)
Results for
"[search-keyword]"
Search
1235 result(s) found, displaying 126 to 150
- Gold Ant tabletsSafety alertsGold Ant tablets pose a serious risk to your health and should not be taken.
- Novartis-Bio Somatropin Human Growth Hormone (HGH)Safety alertsCounterfeit Somatropin Human Growth Hormone (HGH) vials pose a serious risk to your health and should not be taken.
- Ospolot (sulthiame) tablets 200 mgProduct recallsProduct Defect Alert - child-resistant caps may not function correctly
- Hydralyte Strawberry Kiwi Effervescent Electrolyte TabletsProduct recallsRecall due to unacceptable risk in pregnancy
- AstraZeneca ChAdOx1-S COVID-19 vaccineSafety alertsThree additional Australian cases of TTS likely linked to vaccine
- AstraZeneca ChAdOx1-S COVID-19 vaccineSafety alertsThird Australian case of thrombosis with thrombocytopenia likely linked to vaccine
- AstraZeneca ChAdOx1-S COVID-19 vaccineSafety alertsSecond case of thrombosis with thrombocytopenia
- LIFEPAK CR2 DefibrillatorProduct recallsProduct defect correction - lid magnet may dislodge and cause early battery depletion
- Various medicines containing Artemisia annua and Artemisia absinthiumProduct recallsRecall of various medicines containing Artemisia annua and Artemisia absinthium - updated recalled medicines
- AstraZeneca ChAdOx1-S COVID-19 vaccine: no evidence of increased risk of anaphylaxisSafety alertsUpdate - Expert review finds no evidence of increased risk of anaphylaxis
- AstraZeneca ChAdOx1-S COVID-19 vaccine: no proven link with blood clotsSafety alertsUpdate - European and UK reviews find no proven link with blood clots
- COVID-19 vaccines - safety and effectiveness in older adultsSafety alertsData on real-world use of COVID-19 vaccines approved in Australia provides reassurance about their safety in older people
- New legislation to support medicine substitutionsMedicine shortage alertsNew legislation has been passed allowing pharmacists to substitute a medicine when the patient's usual medicine is in 'serious scarcity'.
- Shortage of sertraline tabletsMedicine shortage alertsThe TGA has issued a Serious Shortage Substitution Notice (SSSN) for sertraline tablets
- Resurrection Male Sexual Enhancement CapsulesSafety alertsResurrection Male Sexual Enhancement capsules pose a serious risk to your health and should not be taken.
- Pregabalin and gabapentinSafety alertsSafety advisory - enhanced warnings relating to abuse and dependence
- Ergometrine maleate injection (500 microgram/mL) ampouleMedicine shortage alertsAlternative product approved to address expected shortage
- Medicines containing Eucommia ulmoides (known as Du-Zhong or Tu-chung)Safety alertsSafety advisory – contains latex (statement includes Chinese translation 中文翻译)
- Tenofovir Disoproxil Emtricitabine Mylan 300/200Product recallsRecall - potential for split tablets to lead to ineffective dose